Giuseppe Michieli<p><a href="https://mstdn.science/tags/XBB" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XBB</span></a>.1.5 monovalent <a href="https://mstdn.science/tags/vaccine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>vaccine</span></a> induces lasting cross-reactive responses to <a href="https://mstdn.science/tags/SARS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SARS</span></a>-CoV-2 <a href="https://mstdn.science/tags/variants" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>variants</span></a> such as HV.1 and <a href="https://mstdn.science/tags/JN1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>JN1</span></a>, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific <a href="https://mstdn.science/tags/antibodies" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>antibodies</span></a>, <a href="https://etidiohnew.blogspot.com/2025/03/xbb15-monovalent-vaccine-induces.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">etidiohnew.blogspot.com/2025/0</span><span class="invisible">3/xbb15-monovalent-vaccine-induces.html</span></a></p>